A high incidence of vertebral fracture in women with breast cancer

British Journal of Cancer

Volumn 79, Issue 7-8, 1999, Pages 1179-1181

  Kanis, J A ^a   McCloskey, E V ^a   Powles, T ^b   Paterson, A H G ^c   Ashley, S ^b   Spector, T ^d  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

^c TOM BAKER CANCER CENTRE   (Canada)

^d ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Breast cancer; Skeletal metastases; Vertebral fracture

Indexed keywords

ADULT; AGED; ARTICLE; BONE METABOLISM; BONE METASTASIS; BREAST CANCER; CANCER STATISTICS; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; RISK ASSESSMENT; SOFT TISSUE CANCER; VERTEBRA FRACTURE;

ADMINISTRATION, ORAL; AGE FACTORS; AGED; ANALGESICS, NON-NARCOTIC; ANTINEOPLASTIC AGENTS, HORMONAL; BONE NEOPLASMS; BREAST NEOPLASMS; CLODRONIC ACID; COHORT STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; ODDS RATIO; OSTEOPOROSIS; SPINAL FRACTURES; TAMOXIFEN;

EID: 0033016402     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690188     Document Type: Article

References (16)

1. Breast Cancer Task Force. Treatment Committee (1977) National Cancer Institute, Breast Cancer. Suggested protocol guidelines for combination chemotherapy trials and for combined modality trials. Washington, DC: US Department of Health, Education and Welfare. Publication no. (NIH) 77-1192
2. Filipponi P, Christallini S, Rizzello E, Policani G, Fedeli L, Gregorio F, et al (1996) Cyclical intravenous clodronate in postmenopausal osteoporosis. Results of a long-term trial. Bone 18: 179-184
3. Hayward JL, Meakin JW and Stewart HJ (1978) Assessment of response and recurrence in breast cancer. Semin Oncol 5: 445-449
4. Kanis JA, Powles T, Paterson AHG, McCloskey EV and Ashley S (1996) Clodronate decreases the frequency of skeletal metastases in women with breast cancer. Bone 19: 663-667
5. Kanis JA, Delmas P, Burckhardt P, Cooper C and Torgerson D, on behalf of the EFFO (1997) Guidelines for the diagnosis and management of osteoporosis. Osteoporosis Int 7: 390-406
6. McCloskey EV, Spector TD, Eyres KS, Fern DE, O'Rourke N, Vasikaran S and Kanis JA (1993) The assessment of vertebral deformity - a method for use in population studies and clinical trials. Osteoporosis Int 3: 138-147
7. Orloff JJ, Wu TL and Stewart AF (1989) Parathyroid hormone-like proteins: biochemical responses and receptor interactions. Endocrinol Rev 10: 476-495
8. Paterson AHG, Powles TJ, Kanis JA, McCloskey E, Hanson J and Ashley S (1993) Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer. J Clin Oncol 11: 59-65
9. Powell GJ, Southby J, Danks JA, Stillwell RG, Hayman JA, Henderson MA, et al (1991) Localisation of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites. Cancer Res 51: 3059-3061
10. Powles TJ, Hickish T, Kanis JA, Tidy A and Ashley S (1996) The effect of tamoxifen on lumbar bone mineral density in pre-and postmenopausal women. J Clin Oncol 14: 78-84
11. Powles TJ, McCloskey E, Paterson AHG, Ashley S, Tidy A and Kanis JA (1997) Oral clodronate reduces the loss of bone mineral density in women with operable primary breast cancer. J Clin Oncol, submitted for publication, ASBMR abstract
12. Rivkees AS and Crawford JD (1988) The relationship of gonadal activity and chemotherapy-induced gonadal damage. JAMA 259: 2123-2125
13. Saarto T, Blomqvist C, Valimaki M, Makelo P, Sarna S and Elomaa I (1997) Chemical castration induced by adjuvant cyclophosphamide, methotrexate and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomised study in premenopausal breast cancer patients. J Clin Oncol 15: 1341-1347
14. Spector TD, McCloskey E, Doyle DV and Kanis JA (1993) Prevalence of vertebral fractures in women and the relationship with bone density and symptoms. The Chingford study. J Bone Miner Res 8: 817-822
15. Taube T, Elomaa I, Blomqvist C, Beneton MNC and Kanis JA (1994) Histomorphometric evidence for osteoclast mediated bone resorption in metastatic breast cancer. Bone 15: 161-166
16. Utz JP, Melton LJ, Kan SH and Riggs BL (1987) Risk of osteoporotic fractures in women with breast cancer: a population-based cohort study. J Chron Dis 40: 105-113